In vitro antifungal susceptibilities of five species of Sporothrix

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 2, 2008, Pages 732-734

  Marimon, Rita ^a   Serena, Carolina ^a   Gené, Josepa ^a   Cano, Josep ^a   Guarro, Josep ^a  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBACONAZOLE; AMPHOTERICIN B; ANTIFUNGAL AGENT; EBERCONAZOLE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; POSACONAZOLE; RAVUCONAZOLE; TERBINAFINE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; FUNGUS ISOLATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SPECIES IDENTIFICATION; SPOROTHRIX; SPOROTHRIX BRASILIENSIS; SPOROTHRIX MEXICANA; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS;

ANIMALS; ANTIFUNGAL AGENTS; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY; SPOROTHRIX; SPOROTRICHOSIS;

EID: 38649139353     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01012-07     Document Type: Article

References (21)

1. Conti Díaz, I. A., E. Civila, and E. Gezuele. 1992. Treatment of human cutaneous sporotrichosis with itraconazole. Mycoses 35:153-156.
2. De Araujo, T., A. C. Marques, and F. Kerdel. 2001. Sporotrichosis. Int. J. Dermatol. 40:737-742.
3. Gilgado, F., J. Cano, J. Gené, and J. Guarro. 2005. Molecular phytogeny of the Pseudallescheria boydii species complex: proposal of two new species. J. Clin. Microbiol. 43:4930-4942.
4. Gilgado, F., C. Serena, J. Cano, J. Gené, and J. Guarro. 2006. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob. Agents Chemother. 50:4211-4213.
5. Hay, R. J. 1999. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br. J. Dermatol. 141(Suppl. 56):36-40.
6. Jessup, C. J., N. S. Ryder, and M. A. Ghannoum. 2000. An evaluation of the in vitro activity of terbinafine. Med. Mycol. 38:155-159.
7. Johnson, E. M., A. Szekely, and D. W. Warnock. 1998. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J. Antimicrob. Chemother. 42:741-745.
8. Kan, V. L., and J. E. Bennett. 1988. Efficacies of four antifungal agents in experimental murine sporotrichosis. Antimicrob. Agents Chemother. 32:1619-1623.
9. Kauffman, C., R. Hajjeh, and W. Chapman. 2000. Practice guidelines for the management of patients with sporotrichosis. Clin. Infect. Dis. 30:684-687.
10. Koufopanou, V., A. Burt, T. Szaro, and J. W. Taylor. 2001. Gene genealogies, cryptic species, and molecular evolution in the human pathogen Coccidioides immitis and relatives (Ascomycota, Onygenales). Mol. Biol. Evol. 18:1246-1258.
11. Lortholary, O., D. W. Denning, and B. Dupont. 1999. Endemic mycoses: a treatment update. J. Antimicrob. Chemother. 43:321-331.
12. Marimon, R., J. Cano, J. Gené, D. A. Sutton, M. Kawasaki, and J. Guarro. 2007. Sporothrix brasiliensis, S. globosa and S. mexicana, three new Sporothrix species of clinical interest. J. Clin. Microbiol. 45:3198-3206.
13. Marimon, R., J. Gené, J. Cano, L. Trilles, M. Dos Santos Lazera, and J. Guarro. 2006. Molecular phytogeny of Sporothrix schenckii. J. Clin. Microbiol. 44:3251-3256.
14. McGinnis, M. R., N. Nordoff, R. K. Li, L. Pasarell, and D. W. Warnock. 2001. Sporothrix schenckii sensitivity to voriconazole, itraconazole, and amphotericin B. Med. Mycol. 39:369-371.
15. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
16. O'Donnell, K. 2000. Molecular phytogeny of the Nectria haematococca-Fusarium solani species complex. Mycologia 92:919-938.
17. Pérez, A. 1999. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases. Mycoses 42(Suppl. 2):111-114.
18. Rippon, J. W. 1988. Sporothrichosis, p. 277-302. In J. W. Rippon (ed.), Medical mycology. The pathogenic fungi and the pathogenic actinomycetes, 3rd ed. The W. B. Saunders Company, Philadelphia, PA.
19. Ryder, N. S. 1999. Activity of terbinafine against serious fungal pathogens. Mycoses 42(Suppl. 2):115-119.
20. Sharkey-Mathis, P. K., C. A. Kaufman, J. R. Graybill, D. A. Stevens, T. S. Hostetler, G. Cloud, and W. E. Dismukes. 1993. Treatment of sporotrichosis with itraconazole. Am. J. Med. 95:279-285.
21. Trilles, L., B. Fernández-Torres, M. Dos Santos Lazera, B. Wanke, A. de Oliveira Schubach, R. de Almeida Paes, I. Inza, and J. Guarro. 2005. In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases. Antimicrob. Agents Chemother. 49:3952-3954.